Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine for sedation support during flexible bronchoscopy
IRCT20250923067343N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Intranasal ketamine recipient with Placebo spray recipient (2 arms). Primary endpoints: Occurrence of gag reflex and Severity of gag reflex. Started Feb 2026; status: completed.
02
Drugs
ketamine
Beyond the preview
Go deeper on IRCT20250923067343N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250923067343N2.